{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:04:27Z","timestamp":1759824267162},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T00:00:00Z","timestamp":1449532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T00:00:00Z","timestamp":1449532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Interferon (IFN) therapy is effective in treating cancers, haematological and virus induced diseases. The classical Jak\/Stat pathway of IFN signal transduction leading to changes in transcriptional activity is well established but alone does not explain the whole spectrum of cellular responses to IFN. Gene promoters contain <jats:italic>cis<\/jats:italic>-acting sequences that allow precise and contextual binding of transcription factors, which control gene expression. Using the transcriptional response to IFN as a starting point we report a high frequency of tandem GGAA motifs in the proximal promoters of Interferon stimulated genes, suggesting a key regulatory action. Utilizing the well-characterized anti-viral gene, <jats:italic>OAS1<\/jats:italic>, as an example Interferon stimulated gene promoter containing such a duplicated GGAA motif, we have demonstrated a regulatory role of this promoter in response to IFN by mutation analysis. Furthermore, we identified ELF-1 as a direct binding factor at this motif. Additionally, recruitment of RB1 and SP1 factors to the promoter following IFN stimulation is shown. ELF-1 overexpression enhanced and knockdown of ELF-1 inhibited full activation of <jats:italic>OAS1<\/jats:italic> by IFN stimulation. Collectively, ELF-1 binds an important duplicated GGAA cis-acting element at the <jats:italic>OAS1<\/jats:italic> promoter and in cooperation with RB1 and SP1 recruitment contributes to regulation in response to IFN stimulation.<\/jats:p>","DOI":"10.1038\/srep17497","type":"journal-article","created":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T10:56:54Z","timestamp":1449572214000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The hematopoietic regulator, ELF-1, enhances the transcriptional response to Interferon-\u03b2 of the OAS1 anti-viral gene"],"prefix":"10.1038","volume":"5","author":[{"given":"Steven","family":"Larsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sei-ichi","family":"Tanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiaki","family":"Uchiumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,8]]},"reference":[{"key":"BFsrep17497_CR1","doi-asserted-by":"publisher","first-page":"7368","DOI":"10.1093\/nar\/gkp804","volume":"37","author":"J Boros","year":"2009","unstructured":"Boros, J. et al. Overlapping promoter targeting by Elk-1 and other divergent ETS-domain transcription factor family members. Nucleic Acids Res. 37, 7368\u201380 (2009).","journal-title":"Nucleic Acids Res."},{"key":"BFsrep17497_CR2","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/j.1365-2443.2008.01240.x","volume":"13","author":"F Uchiumi","year":"2008","unstructured":"Uchiumi, F., Sakakibara, G., Sato, J. & Tanuma, S. Characterization of the promoter region of the human PARG gene and its response to PU.1 during differentiation of HL-60 cells. Genes Cells 13, 1229\u201347 (2008).","journal-title":"Genes Cells"},{"key":"BFsrep17497_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.gene.2010.04.014","volume":"463","author":"F Uchiumi","year":"2010","unstructured":"Uchiumi, F., Enokida, K., Shiraishi, T., Masumi, A. & Tanuma, S.-I. Characterization of the promoter region of the human IGHMBP2 (Smubp-2) gene and its response to TPA in HL-60 cells. Gene 463, 8\u201317 (2010).","journal-title":"Gene"},{"key":"BFsrep17497_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1874609811104010001","volume":"4","author":"F Uchiumi","year":"2011","unstructured":"Uchiumi, F. et al. The effect of resveratrol on the Werner syndrome RecQ helicase gene and telomerase activity. Curr Aging Sci 4, 1\u20137 (2011).","journal-title":"Curr Aging Sci"},{"key":"BFsrep17497_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","volume":"1","author":"JW Schoggins","year":"2011","unstructured":"Schoggins, J. W. & Rice, C. M. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 1, 519\u201325 (2011).","journal-title":"Curr Opin Virol"},{"key":"BFsrep17497_CR6","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1084\/jem.20101159","volume":"208","author":"MB Fuertes","year":"2011","unstructured":"Fuertes, M. B. et al. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells. J Exp Med 208, 2005\u201316 (2011).","journal-title":"J Exp Med"},{"key":"BFsrep17497_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","volume":"67","author":"GR Stark","year":"1998","unstructured":"Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H. & Schreiber, R. D. How cells respond to interferons. Annu Rev Biochem 67, 227\u201364 (1998).","journal-title":"Annu Rev Biochem"},{"key":"BFsrep17497_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/0092-8674(84)90270-8","volume":"38","author":"RL Friedman","year":"1984","unstructured":"Friedman, R. L., Manly, S. P., McMahon, M., Kerr, I. M. & Stark, G. R. Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38, 745\u2013755 (1984).","journal-title":"Cell"},{"key":"BFsrep17497_CR9","doi-asserted-by":"publisher","first-page":"49428","DOI":"10.1074\/jbc.M205571200","volume":"277","author":"JF Schlaak","year":"2002","unstructured":"Schlaak, J. F. et al. Cell-type and donor-specific transcriptional responses to interferon-alpha. Use of customized gene arrays. J Biol Chem 277, 49428\u201337 (2002).","journal-title":"J Biol Chem"},{"key":"BFsrep17497_CR10","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.4049\/jimmunol.0902314","volume":"185","author":"AHH Van Boxel-Dezaire","year":"2010","unstructured":"Van Boxel-Dezaire, A. H. H. et al. Major differences in the responses of primary human leukocyte subsets to IFN-beta. J Immunol 185, 5888\u201399 (2010).","journal-title":"J Immunol"},{"key":"BFsrep17497_CR11","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","volume":"339","author":"JG McHutchison","year":"1998","unstructured":"McHutchison, J. G. et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339, 1485\u201392 (1998).","journal-title":"N Engl J Med"},{"key":"BFsrep17497_CR12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.nurt.2007.07.001","volume":"4","author":"RA Bermel","year":"2007","unstructured":"Bermel, R. A. & Rudick, R. A. Interferon-beta treatment for multiple sclerosis. Neurotherapeutics 4, 633\u201346 (2007).","journal-title":"Neurotherapeutics"},{"key":"BFsrep17497_CR13","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nrd2422","volume":"6","author":"EC Borden","year":"2007","unstructured":"Borden, E. C. et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 6, 975\u201390 (2007).","journal-title":"Nat Rev Drug Discov"},{"key":"BFsrep17497_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.immuni.2006.08.014","volume":"25","author":"AHH Van Boxel-Dezaire","year":"2006","unstructured":"Van Boxel-Dezaire, A. H. H., Rani, M. R. S. & Stark, G. R. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25, 361\u201372 (2006).","journal-title":"Immunity"},{"key":"BFsrep17497_CR15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.biochi.2007.02.003","volume":"89","author":"AG Hovanessian","year":"2007","unstructured":"Hovanessian, A. G. & Justesen, J. The human 2\u2032-5\u2032 oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2\u2032-5\u2032 instead of 3\u2032-5\u2032 phosphodiester bond formation. Biochimie 89, 779\u201388 (2007).","journal-title":"Biochimie"},{"key":"BFsrep17497_CR16","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1093\/nar\/26.6.1522","volume":"26","author":"S Naik","year":"1998","unstructured":"Naik, S., Paranjape, J. M. & Silverman, R. H. RNase L dimerization in a mammalian two-hybrid system in response to 2\u2032,5\u2032-oligoadenylates. Nucleic Acids Res 26, 1522\u20137 (1998).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep17497_CR17","doi-asserted-by":"publisher","first-page":"5509","DOI":"10.1002\/cncr.26219","volume":"117","author":"S Mandal","year":"2011","unstructured":"Mandal, S., Abebe, F. & Chaudhary, J. 2\u2032-5\u2032 oligoadenylate synthetase 1 polymorphism is associated with prostate cancer. Cancer 117, 5509\u201318 (2011).","journal-title":"Cancer"},{"key":"BFsrep17497_CR18","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1182\/blood-2010-09-309468","volume":"117","author":"H-J Choi","year":"2011","unstructured":"Choi, H.-J. et al. Differential requirements for the Ets transcription factor Elf-1 in the development of NKT cells and NK cells. Blood 117, 1880\u20137 (2011).","journal-title":"Blood"},{"key":"BFsrep17497_CR19","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1084\/jem.183.3.743","volume":"183","author":"S John","year":"1996","unstructured":"John, S., Marais, R., Child, R., Light, Y. & Leonard, W. J. Importance of low affinity Elf-1 sites in the regulation of lymphoid-specific inducible gene expression. J Exp Med 183, 743\u201350 (1996).","journal-title":"J Exp Med"},{"key":"BFsrep17497_CR20","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1093\/emboj\/cdf286","volume":"21","author":"B G\u00f6ttgens","year":"2002","unstructured":"G\u00f6ttgens, B. et al. Establishing the transcriptional programme for blood: the SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors. EMBO J 21, 3039\u201350 (2002).","journal-title":"EMBO J"},{"key":"BFsrep17497_CR21","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1182\/blood-2005-08-3206","volume":"107","author":"X Huang","year":"2006","unstructured":"Huang, X. et al. Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis. Blood 107, 3153\u201360 (2006).","journal-title":"Blood"},{"key":"BFsrep17497_CR22","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.1093\/nar\/gkq490","volume":"38","author":"FJ Calero-Nieto","year":"2010","unstructured":"Calero-Nieto, F. J. et al. Transcriptional regulation of Elf-1: locus-wide analysis reveals four distinct promoters, a tissue-specific enhancer, control by PU.1 and the importance of Elf-1 downregulation for erythroid maturation. Nucleic Acids Res 38, 6363\u201374 (2010).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep17497_CR23","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.4049\/jimmunol.168.6.2865","volume":"168","author":"Y-T Juang","year":"2002","unstructured":"Juang, Y.-T., Solomou, E. E., Rellahan, B. & Tsokos, G. C. Phosphorylation and O-linked glycosylation of Elf-1 leads to its translocation to the nucleus and binding to the promoter of the TCR zeta-chain. J Immunol 168, 2865\u201371 (2002).","journal-title":"J Immunol"},{"key":"BFsrep17497_CR24","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1126\/science.8493578","volume":"260","author":"CY Wang","year":"1993","unstructured":"Wang, C. Y., Petryniak, B., Thompson, C. B., Kaelin, W. G. & Leiden, J. M. Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science (80-.). 260, 1330\u20135 (1993).","journal-title":"Science (80-.)."},{"key":"BFsrep17497_CR25","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1007\/s00018-011-0674-x","volume":"68","author":"F Uchiumi","year":"2011","unstructured":"Uchiumi, F., Miyazaki, S. & Tanuma, S. The possible functions of duplicated ets (GGAA) motifs located near transcription start sites of various human genes. Cell Mol Life Sci 68, 2039\u201351 (2011).","journal-title":"Cell Mol Life Sci"},{"key":"BFsrep17497_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/sj.gene.6363984","volume":"4","author":"S Knapp","year":"2003","unstructured":"Knapp, S. et al. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun 4, 411\u20139 (2003).","journal-title":"Genes Immun"},{"key":"BFsrep17497_CR27","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1128\/MCB.7.12.4498","volume":"7","author":"P Benech","year":"1987","unstructured":"Benech, P., Vigneron, M., Peretz, D., Revel, M. & Chebath, J. Interferon-responsive regulatory elements in the promoter of the human 2\u2032,5\u2032-oligo(A) synthetase gene. Mol. Cell. Biol. 7, 4498\u2013504 (1987).","journal-title":"Mol. Cell. Biol."},{"key":"BFsrep17497_CR28","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1128\/MCB.01808-08","volume":"29","author":"I Moraga","year":"2009","unstructured":"Moraga, I., Harari, D., Schreiber, G., Uz\u00e9, G. & Pellegrini, S. Receptor density is key to the alpha2\/beta interferon differential activities. Mol Cell Biol 29, 4778\u201387 (2009).","journal-title":"Mol Cell Biol"},{"key":"BFsrep17497_CR29","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/j.1460-2075.1988.tb02872.x","volume":"7","author":"MN Rutherford","year":"1988","unstructured":"Rutherford, M. N., Hannigan, G. E. & Williams, B. R. Interferon-induced binding of nuclear factors to promoter elements of the 2-5A synthetase gene. EMBO J. 7, 751\u20139 (1988).","journal-title":"EMBO J."},{"key":"BFsrep17497_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1023\/A:1007177623283","volume":"210","author":"M Gunther","year":"2000","unstructured":"Gunther, M., Laithier, M. & Brison, O. A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening. Mol Cell Biochem 210, 131\u201342 (2000).","journal-title":"Mol Cell Biochem"},{"key":"BFsrep17497_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.genom.7.080505.115623","volume":"7","author":"GA Maston","year":"2006","unstructured":"Maston, G. A., Evans, S. K. & Green, M. R. Transcriptional regulatory elements in the human genome. Annu Rev Genomics Hum Genet 7, 29\u201359 (2006).","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"BFsrep17497_CR32","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1038\/emboj.2010.106","volume":"29","author":"G-H Wei","year":"2010","unstructured":"Wei, G.-H. et al. Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. EMBO J. 29, 2147\u201360 (2010).","journal-title":"EMBO J."},{"key":"BFsrep17497_CR33","unstructured":"Uchiumi, F., Larsen, S., Masumi, A. & Tanuma, S. In Genomics I-Humans, Anim. Plants (iConcept Press Ltd, 2013)."},{"key":"BFsrep17497_CR34","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1101\/gr.093047.109","volume":"19","author":"J Boros","year":"2009","unstructured":"Boros, J. et al. Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery. Genome Res. 19, 1963\u201373 (2009).","journal-title":"Genome Res."},{"key":"BFsrep17497_CR35","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1182\/blood-2005-01-0080","volume":"106","author":"T Tamura","year":"2005","unstructured":"Tamura, T., Thotakura, P., Tanaka, T. S., Ko, M. S. H. & Ozato, K. Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages. Blood 106, 1938\u201347 (2005).","journal-title":"Blood"},{"key":"BFsrep17497_CR36","doi-asserted-by":"publisher","first-page":"21909","DOI":"10.1074\/jbc.M212150200","volume":"278","author":"D O\u2019Reilly","year":"2003","unstructured":"O\u2019Reilly, D., Quinn, C. M., El-Shanawany, T., Gordon, S. & Greaves, D. R. Multiple Ets factors and interferon regulatory factor-4 modulate CD68 expression in a cell type-specific manner. J Biol Chem 278, 21909\u201319 (2003).","journal-title":"J Biol Chem"},{"key":"BFsrep17497_CR37","doi-asserted-by":"publisher","first-page":"e22200","DOI":"10.1371\/journal.pone.0022200","volume":"6","author":"V Fran\u00e7ois-Newton","year":"2011","unstructured":"Fran\u00e7ois-Newton, V. et al. USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon \u03b1 response. PLoS One 6, e22200 (2011).","journal-title":"PLoS One"},{"key":"BFsrep17497_CR38","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1128\/MCB.12.3.1043","volume":"12","author":"CB Thompson","year":"1992","unstructured":"Thompson, C. B. et al. cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1. Mol Cell Biol 12, 1043\u201353 (1992).","journal-title":"Mol Cell Biol"},{"key":"BFsrep17497_CR39","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/323643a0","volume":"323","author":"SH Friend","year":"1986","unstructured":"Friend, S. H. et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323, 643\u20136 (1986).","journal-title":"Nature"},{"key":"BFsrep17497_CR40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrm3567","volume":"14","author":"FA Dick","year":"2013","unstructured":"Dick, F. A. & Rubin, S. M. Molecular mechanisms underlying RB protein function. Nat Rev Mol Cell Biol 14, 297\u2013306 (2013).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFsrep17497_CR41","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrc2399","volume":"8","author":"DL Burkhart","year":"2008","unstructured":"Burkhart, D. L. & Sage, J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 8, 671\u201382 (2008).","journal-title":"Nat Rev Cancer"},{"key":"BFsrep17497_CR42","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias, L. C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5, 375\u201386 (2005).","journal-title":"Nat Rev Immunol"},{"key":"BFsrep17497_CR43","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/jvh.12008","volume":"19","author":"P Bruggmann","year":"2012","unstructured":"Bruggmann, P. Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers. J. Viral Hepat. 19, 829\u201335 (2012).","journal-title":"J. Viral Hepat."},{"key":"BFsrep17497_CR44","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.4049\/jimmunol.1290060","volume":"189","author":"AA Tarhini","year":"2012","unstructured":"Tarhini, A. A., Gogas, H. & Kirkwood, J. M. IFN-\u03b1 in the treatment of melanoma. J Immunol 189, 3789\u201393 (2012).","journal-title":"J Immunol"},{"key":"BFsrep17497_CR45","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.yexcr.2011.03.002","volume":"317","author":"RA Rudick","year":"2011","unstructured":"Rudick, R. A. & Goelz, S. E. Beta-interferon for multiple sclerosis. Exp Cell Res 317, 1301\u201311 (2011).","journal-title":"Exp Cell Res"},{"key":"BFsrep17497_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00439-011-1053-2","volume":"131","author":"R Cagliani","year":"2012","unstructured":"Cagliani, R. et al. Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis. Hum Genet 131, 87\u201397 (2012).","journal-title":"Hum Genet"},{"key":"BFsrep17497_CR47","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1128\/jvi.66.10.5890-5897.1992","volume":"66","author":"JM Leiden","year":"1992","unstructured":"Leiden, J. M. et al. A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells. J Virol 66, 5890\u20137 (1992).","journal-title":"J Virol"},{"key":"BFsrep17497_CR48","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1097\/01.LAB.0000035025.51772.2B","volume":"82","author":"F Baran-Marszak","year":"2002","unstructured":"Baran-Marszak, F. et al. Gene array identification of Epstein Barr virus-regulated cellular genes in EBV-converted Burkitt lymphoma cell lines. Lab Invest 82, 1463\u201379 (2002).","journal-title":"Lab Invest"},{"key":"BFsrep17497_CR49","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1128\/jvi.67.9.5522-5528.1993","volume":"67","author":"NM Clark","year":"1993","unstructured":"Clark, N. M., Smith, M. J., Hilfinger, J. M. & Markovitz, D. M. Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor. J Virol 67, 5522\u20138 (1993).","journal-title":"J Virol"},{"key":"BFsrep17497_CR50","doi-asserted-by":"publisher","first-page":"W86","DOI":"10.1093\/nar\/gkr377","volume":"39","author":"M Thomas-Chollier","year":"2011","unstructured":"Thomas-Chollier, M. et al. RSAT 2011: regulatory sequence analysis tools. Nucleic Acids Res 39, W86\u201391 (2011).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep17497_CR51","doi-asserted-by":"publisher","first-page":"W119","DOI":"10.1093\/nar\/gkn304","volume":"36","author":"M Thomas-Chollier","year":"2008","unstructured":"Thomas-Chollier, M. et al. RSAT: regulatory sequence analysis tools. Nucleic Acids Res 36, W119\u201327 (2008).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep17497_CR52","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1093\/nar\/gkg567","volume":"31","author":"J Van Helden","year":"2003","unstructured":"Van Helden, J. Regulatory sequence analysis tools. Nucleic Acids Res 31, 3593\u20136 (2003).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep17497_CR53","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.yexcr.2010.03.009","volume":"316","author":"F Uchiumi","year":"2010","unstructured":"Uchiumi, F., Watanabe, T. & Tanuma, S. Characterization of various promoter regions of the human DNA helicase-encoding genes and identification of duplicated ets (GGAA) motifs as an essential transcription regulatory element. Exp Cell Res 316, 1523\u201334 (2010).","journal-title":"Exp Cell Res"},{"key":"BFsrep17497_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/08924562.1996.11000299","volume":"9","author":"C Papworth","year":"1996","unstructured":"Papworth, C., Bauer, J., Braman, J. & Wright., D. Site-directed mutagenesis in one day with &gt;80% efficiency. Strategies 9, 3\u20134 (1996).","journal-title":"Strategies"},{"key":"BFsrep17497_CR55","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/nar\/11.5.1475","volume":"11","author":"JD Dignam","year":"1983","unstructured":"Dignam, J. D., Lebovitz, R. M. & Roeder, R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11, 1475\u201389 (1983).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep17497_CR56","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bbrc.2009.12.010","volume":"392","author":"S Larsen","year":"2010","unstructured":"Larsen, S. et al. LMO3 interacts with p53 and inhibits its transcriptional activity. Biochem Biophys Res Commun 392, 252\u20137 (2010).","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep17497","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep17497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep17497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T19:24:17Z","timestamp":1672946657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep17497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,8]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,22]]}},"alternative-id":["BFsrep17497"],"URL":"https:\/\/doi.org\/10.1038\/srep17497","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,8]]},"assertion":[{"value":"21 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17497"}}